FAM117A Is a New Prognostic Marker of Lung Adenocarcinoma and Predicts Sensitivity to PD0332991

Lung cancer is the second most common cancer and the leading cause for cancer mortality worldwide. Accelerated cell cycle progression is a well-characterized hallmark for cancer. The present study aims to identify biomarkers for clinical outcomes of lung cancer patients and their sensitivity to CDK...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chao, Zhang, Jiajin, Wang, Kuan, Fan, Mengjiao, Hu, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913056/
https://www.ncbi.nlm.nih.gov/pubmed/35280504
http://dx.doi.org/10.1155/2022/3945446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913056/
https://www.ncbi.nlm.nih.gov/pubmed/35280504
http://dx.doi.org/10.1155/2022/3945446

Ejemplares similares